Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Two Years of Ocrelizumab Treatment in Black and Hispanic People with Multiple Sclerosis in CHIMES: A Single-Arm Clinical Trial.
Journal: Annals of neurology
Published: September 24, 2025
Understanding Diverse Caregiver Experiences and Their Impact on Caregiver Burden in Multiple Sclerosis.
Journal: International journal of MS care
Published: April 30, 2025
Long-Term Safety and Effectiveness of Dimethyl Fumarate in Patients with Multiple Sclerosis Treated in Routine Medical Practice: Final Analysis of the ESTEEM Study.
Journal: Neurology and therapy
Published: August 12, 2024
Real-world clinical utility of a multi-protein, blood-based biomarker assay for disease activity assessments in multiple sclerosis.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: July 29, 2024
Cladribine tablets after treatment with natalizumab (CLADRINA) - rationale and design.
Journal: Therapeutic advances in neurological disorders
Published: December 12, 2023
Cognitive Symptom Awareness Among Patients With Multiple Sclerosis Using a Mobile Application.
Journal: Rehabilitation nursing : the official journal of the Association of Rehabilitation Nurses
Published: December 12, 2023
Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM.
Journal: Neurology and therapy
Published: March 10, 2023
Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial.
Journal: Multiple sclerosis and related disorders
Published: November 07, 2022
Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome.
Journal: Annals of neurology
Published: September 20, 2022
The sequential natalizumab - alemtuzumab therapy in patients with relapsing forms of multiple sclerosis (SUPPRESS) trial - Part I: Rationale and objectives.
Journal: Journal of central nervous system disease
Published: September 05, 2022
Advancing Care and Outcomes for African American Patients With Multiple Sclerosis.
Journal: Neurology
Published: October 29, 2021
Last Updated: 09/26/2026